Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (JNJ)
:JNJ
Intralipid, Ici35,868 (Diprivan), Ici35,868 (Diprivan) + Ees0000645/A (Sds)
Sedation To Be Moderate For A Diagnostic Gastrointestinal Endoscopy And Gastrointestinal Endoscopic Polypectomy
Phase III
Completed
Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy
Oct 10, 2013
―
Golimumab
Spondylitis, Ankylosing
Phase III
Completed
Effect of Golimumab in Participants With Active Axial Spondyloarthritis (P07642, MK-8259-006)
Oct 13, 2011
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Johnson & Johnson (JNJ) have in its pipeline
JNJ is currently developing the following drugs: Intralipid, Ici35,868 (Diprivan), Ici35,868 (Diprivan) + Ees0000645/A (Sds), Golimumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.